Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Paclitaxel | hsa00010 | Glycolysis / Gluconeogenesis | 1.18E-02 | 2 | P60174, P06744 | TPI1, GPI | More | | Paclitaxel | hsa00052 | Galactose metabolism | 1.03E-02 | 2 | P06280, O43451 | GLA, MGAM | More | | Paclitaxel | hsa00053 | Ascorbate and aldarate metabolism | 1.80E-02 | 2 | P51648, Q9UEF7 | ALDH3A2, KL | More | | Paclitaxel | hsa00190 | Oxidative phosphorylation | 3.56E-02 | 3 | Q16718, Q13488, O14521 | NDUFA5, TCIRG1, SDHD | More | | Paclitaxel | hsa00230 | Purine metabolism | 1.81E-02 | 2 | P20839, Q02153 | IMPDH1, GUCY1B3 | More | | Paclitaxel | hsa00260 | Glycine, serine and threonine metabolism | 1.99E-02 | 1 | P22557 | ALAS2 | More | | Paclitaxel | hsa00310 | Lysine degradation | 4.27E-02 | 2 | Q96KQ7, P51648 | EHMT2, ALDH3A2 | More | | Paclitaxel | hsa00500 | Starch and sucrose metabolism | 1.10E-03 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Paclitaxel | hsa00533 | Glycosaminoglycan biosynthesis - keratan sulfate | 3.43E-02 | 1 | Q9NY97 | B3GNT2 | More | | Paclitaxel | hsa00561 | Glycerolipid metabolism | 4.36E-03 | 3 | O14494, P51648, P23743 | PLPP1, ALDH3A2, DGKA | More | | Paclitaxel | hsa00565 | Ether lipid metabolism | 3.94E-02 | 1 | Q8N661 | TMEM86B | More | | Paclitaxel | hsa00630 | Glyoxylate and dicarboxylate metabolism | 2.42E-02 | 2 | P40925, P15104 | MDH1, GLUL | More | | Paclitaxel | hsa00730 | Thiamine metabolism | 5.29E-03 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Paclitaxel | hsa00983 | Drug metabolism - other enzymes | 2.44E-02 | 2 | P32320, P05164 | CDA, MPO | More | | Paclitaxel | hsa01200 | Carbon metabolism | 1.99E-02 | 2 | P06744, P60174 | GPI, TPI1 | More | | Paclitaxel | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 2.90E-02 | 3 | P17252, P10415, Q9NRA1 | PRKCA, BCL2, PDGFC | More | | Paclitaxel | hsa01523 | Antifolate resistance | 3.80E-02 | 2 | Q92820, P04818 | GGH, TYMS | More | | Paclitaxel | hsa01524 | Platinum drug resistance | 4.02E-02 | 4 | Q13315, P10415, Q13489, P43246 | ATM, BCL2, BIRC3, MSH2 | More | | Paclitaxel | hsa03013 | RNA transport | 3.98E-02 | 9 | P52298, Q09161, O14893, Q7Z3B4, P35658, Q14152, O75822, P78345, Q9Y6A5 | NCBP2, NCBP1, GEMIN2, NUP54, NUP214, EIF3A, EIF3J, RPP38, TACC3 | More | | Paclitaxel | hsa03040 | Spliceosome | 1.45E-04 | 11 | Q14562, O43143, O60508, P26368, P52298, Q13595, Q07955, Q01130, P84103, Q13243, P11142 | DHX8, DHX15, CDC40, U2AF2, NCBP2, TRA2A, SFRS1, SFRS2, SFRS3, SFRS5, HSPA8 | More | | Paclitaxel | hsa04020 | Calcium signaling pathway | 2.09E-02 | 5 | Q16566, P17252, P25116, P0DP23, Q9NRA1 | CAMK4, PRKCA, F2R, CALM1, PDGFC | More | | Paclitaxel | hsa04060 | Cytokine-cytokine receptor interaction | 2.19E-02 | 11 | P32927, P27930, Q13651, P25024, P25025, Q9UBD3, P47992, P09341, P32248, P18510, P01730 | CSF2RB, IL1R2, IL10RA, CXCR1, CXCR2, XCL2, XCL1, CXCL1, CCR7, IL1RN, CD4 | More | | Paclitaxel | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 8.11E-03 | 7 | P32248, P09341, P25024, P25025, P47992, Q9UBD3, Q13651 | CCR7, CXCL1, CXCR1, CXCR2, XCL1, XCL2, IL10RA | More | | Paclitaxel | hsa04064 | NF-kappa B signaling pathway | 3.04E-03 | 8 | P10415, Q13489, P25963, P51617, Q13546, Q9UDY8, Q13315, O75293 | BCL2, BIRC3, NFKBIA, IRAK1, RIPK1, MALT1, ATM, GADD45B | More | | Paclitaxel | hsa04071 | Sphingolipid signaling pathway | 1.10E-03 | 7 | P17252, P21453, Q9H228, P01375, P10415, Q9UQC2, P01042 | PRKCA, S1PR1, EDG8, TNF, BCL2, GAB2, KNG1 | More | | Paclitaxel | hsa04072 | Phospholipase D signaling pathway | 1.06E-02 | 5 | P25116, P17252, O14494, P23743, Q9NRA1 | F2R, PRKCA, PLPP1, DGKA, PDGFC | More | | Paclitaxel | hsa04110 | Cell cycle | 6.80E-03 | 6 | P06493, O75293, P30304, P33981, P42773, P01106 | CDK1, GADD45B, CDC25A, TTK, CDKN2C, MYC | More | | Paclitaxel | hsa04120 | Ubiquitin mediated proteolysis | 2.89E-02 | 2 | O95071, P0CG47 | UBR5, UBB | More | | Paclitaxel | hsa04137 | Mitophagy - animal | 9.52E-03 | 2 | Q07817, P0CG47 | BCL2L1, UBB | More | | Paclitaxel | hsa04141 | Protein processing in endoplasmic reticulum | 2.77E-02 | 5 | P27824, P30101, P60604, P11142, P08238 | CANX, PDIA3, UBE2G2, HSPA8, HSP90AB1 | More | | Paclitaxel | hsa04145 | Phagosome | 1.69E-05 | 10 | Q15080, P14598, Q13509, P68371, Q13488, P05164, O60603, P35443, P27824, P13765 | NCF4, NCF1, TUBB3, TUBB2C, TCIRG1, MPO, TLR2, THBS4, CANX, HLA-DOB | More | | Paclitaxel | hsa04210 | Apoptosis | 3.58E-02 | 4 | O76075, P01375, Q9NR28, Q16548 | DFFB, TNF, DIABLO, BCL2A1 | More | | Paclitaxel | hsa04215 | Apoptosis - multiple species | 1.56E-02 | 2 | Q13489, P10415 | BIRC3, BCL2 | More | | Paclitaxel | hsa04217 | Necroptosis | 3.69E-05 | 8 | P01568, Q13489, Q13546, P42224, P08238, Q6FI13, P10415, O43633 | IFNA21, BIRC3, RIPK1, STAT1, HSP90AB1, H2AC18; H2AC19, BCL2, CHMP2A | More | | Paclitaxel | hsa04218 | Cellular senescence | 4.79E-02 | 4 | P01106, O75293, P30304, P06493 | MYC, GADD45B, CDC25A, CDK1 | More | | Paclitaxel | hsa04340 | Hedgehog signaling pathway | 3.32E-02 | 2 | P49841, P22694 | GSK3B, PRKACB | More | | Paclitaxel | hsa04371 | Apelin signaling pathway | 1.12E-03 | 9 | P62873, P63218, P50151, Q13370, Q14344, Q13485, P84022, Q16566, P0DP23 | GNB1, GNG5, GNG10, PDE3B, GNA13, SMAD4, SMAD3, CAMK4, CALM1 | More | | Paclitaxel | hsa04390 | Hippo signaling pathway | 2.08E-02 | 3 | P84022, Q13485, Q13489 | SMAD3, SMAD4, BIRC3 | More | | Paclitaxel | hsa04520 | Adherens junction | 8.77E-03 | 4 | Q13485, P84022, O95863, Q15223 | SMAD4, SMAD3, SNAI1, PVRL1 | More | | Paclitaxel | hsa04540 | Gap junction | 5.44E-03 | 4 | P17252, Q13509, P68371, Q9NRA1 | PRKCA, TUBB3, TUBB2C, PDGFC | More | | Paclitaxel | hsa04620 | Toll-like receptor signaling pathway | 7.24E-03 | 5 | P51617, Q13546, P01568, P42224, P25963 | IRAK1, RIPK1, IFNA21, STAT1, NFKBIA | More | | Paclitaxel | hsa04621 | NOD-like receptor signaling pathway | 4.54E-02 | 7 | P08238, P42224, P01568, P25963, Q13489, P10415, Q13546 | HSP90AB1, STAT1, IFNA21, NFKBIA, BIRC3, BCL2, RIPK1 | More | | Paclitaxel | hsa04623 | Cytosolic DNA-sensing pathway | 4.52E-05 | 3 | P01568, Q13546, P25963 | IFNA21, RIPK1, NFKBIA | More | | Paclitaxel | hsa04640 | Hematopoietic cell lineage | 3.69E-02 | 4 | P21926, P07766, P01730, P09564 | CD9, CD3E, CD4, CD7 | More | | Paclitaxel | hsa04657 | IL-17 signaling pathway | 3.31E-02 | 3 | P49841, P14780, P01375 | GSK3B, MMP9, TNF | More | | Paclitaxel | hsa04658 | Th1 and Th2 cell differentiation | 1.06E-03 | 8 | Q04759, P20963, P09693, Q16539, P01730, P23771, Q9UL17, P13765 | PRKCQ, CD247, CD3G, MAPK14, CD4, GATA3, TBX21, HLA-DOB | More | | Paclitaxel | hsa04659 | Th17 cell differentiation | 3.97E-05 | 14 | P25963, Q04759, Q16539, P19174, P01730, P13765, Q9UL17, P23771, P84022, Q13485, P08238, P07766, P09693, P20963 | NFKBIA, PRKCQ, MAPK14, PLCG1, CD4, HLA-DOB, TBX21, GATA3, SMAD3, SMAD4, HSP90AB1, CD3E, CD3G, CD247 | More | | Paclitaxel | hsa04660 | T cell receptor signaling pathway | 1.33E-02 | 8 | Q04759, O95267, Q08881, P20963, P09693, P01730, Q16539, P49841 | PRKCQ, RASGRP1, ITK, CD247, CD3G, CD4, MAPK14, GSK3B | More | | Paclitaxel | hsa04664 | Fc epsilon RI signaling pathway | 2.35E-02 | 3 | P07948, P19174, P09917 | LYN, PLCG1, ALOX5 | More | | Paclitaxel | hsa04666 | Fc gamma R-mediated phagocytosis | 1.76E-03 | 5 | P23528, P06396, O14494, P14598, P17252 | CFL1, GSN, PLPP1, NCF1, PRKCA | More | | Paclitaxel | hsa04672 | Intestinal immune network for IgA production | 1.62E-02 | 3 | P29965, P10747, P13765 | CD40LG, CD28, HLA-DOB | More | | Paclitaxel | hsa04710 | Circadian rhythm | 6.85E-04 | 3 | O15516, Q16526, Q9Y478 | CLOCK, CRY1, PRKAB1 | More | | Paclitaxel | hsa04720 | Long-term potentiation | 2.05E-02 | 3 | P17252, Q16566, P0DP23 | PRKCA, CAMK4, CALM1 | More | | Paclitaxel | hsa04724 | Glutamatergic synapse | 4.43E-02 | 3 | P63218, P50151, P15104 | GNG5, GNG10, GLUL | More | | Paclitaxel | hsa04725 | Cholinergic synapse | 8.04E-03 | 4 | P17252, P62873, Q16566, P10415 | PRKCA, GNB1, CAMK4, BCL2 | More | | Paclitaxel | hsa04727 | GABAergic synapse | 4.43E-02 | 3 | P63218, P50151, P15104 | GNG5, GNG10, GLUL | More | | Paclitaxel | hsa04744 | Phototransduction | 2.95E-06 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Paclitaxel | hsa04910 | Insulin signaling pathway | 2.35E-02 | 3 | P22694, P06737, P49841 | PRKACB, PYGL, GSK3B | More | | Paclitaxel | hsa04916 | Melanogenesis | 3.86E-03 | 4 | P0DP23, Q9UJU2, P17252, P04628 | CALM1, LEF1, PRKCA, WNT1 | More | | Paclitaxel | hsa04919 | Thyroid hormone signaling pathway | 7.11E-03 | 4 | P49841, P22694, O60244, Q9NVC6 | GSK3B, PRKACB, MED14, MED17 | More | | Paclitaxel | hsa04920 | Adipocytokine signaling pathway | 4.31E-02 | 2 | Q9Y478, Q96RR4 | PRKAB1, CAMKK2 | More | | Paclitaxel | hsa04925 | Aldosterone synthesis and secretion | 3.91E-02 | 3 | P0DP23, P17252, Q16566 | CALM1, PRKCA, CAMK4 | More | | Paclitaxel | hsa04931 | Insulin resistance | 1.94E-02 | 3 | P01375, P49841, P06737 | TNF, GSK3B, PYGL | More | | Paclitaxel | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 1.25E-02 | 3 | P84022, Q13485, P10415 | SMAD3, SMAD4, BCL2 | More | | Paclitaxel | hsa04961 | Endocrine and other factor-regulated calcium reabsorption | 1.22E-02 | 3 | P20020, Q9UEF7, P17252 | ATP2B1, KL, PRKCA | More | | Paclitaxel | hsa04975 | Fat digestion and absorption | 3.43E-02 | 1 | O14494 | PLPP1 | More | | Paclitaxel | hsa04976 | Bile secretion | 2.44E-02 | 2 | P22694, P08183 | PRKACB, ABCB1 | More | | Paclitaxel | hsa05032 | Morphine addiction | 4.43E-02 | 3 | P63218, P50151, P43250 | GNG5, GNG10, GRK6 | More | | Paclitaxel | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 4.11E-02 | 4 | Q16539, P09341, P25024, P25025 | MAPK14, CXCL1, CXCR1, CXCR2 | More | | Paclitaxel | hsa05132 | Salmonella infection | 3.63E-07 | 13 | P51617, P25963, P08238, Q9UJU2, Q13546, Q13489, P10415, O75369, O60603, Q9BQS8, Q13561, Q13509, P68371 | IRAK1, NFKBIA, HSP90AB1, LEF1, RIPK1, BIRC3, BCL2, FLNB, TLR2, FYCO1, DCTN2, TUBB3, TUBB2C | More | | Paclitaxel | hsa05140 | Leishmaniasis | 4.05E-03 | 6 | P14598, P42224, P25963, P29350, P51617, Q15080 | NCF1, STAT1, NFKBIA, PTPN6, IRAK1, NCF4 | More | | Paclitaxel | hsa05145 | Toxoplasmosis | 1.95E-03 | 6 | P51617, P25963, P10415, Q13489, P42224, P11142 | IRAK1, NFKBIA, BCL2, BIRC3, STAT1, HSPA8 | More | | Paclitaxel | hsa05152 | Tuberculosis | 1.40E-05 | 11 | Q13488, P0DP23, P42224, P48382, P25208, O60603, P10415, P13765, P01568, Q9UDY8, P51617 | TCIRG1, CALM1, STAT1, RFX5, NFYB, TLR2, BCL2, HLA-DOB, IFNA21, MALT1, IRAK1 | More | | Paclitaxel | hsa05161 | Hepatitis B | 8.49E-03 | 4 | P25963, Q13485, P10415, P84022 | NFKBIA, SMAD4, BCL2, SMAD3 | More | | Paclitaxel | hsa05162 | Measles | 4.50E-03 | 8 | P51617, P01568, P25963, P42224, P14784, P10747, P11142, P10415 | IRAK1, IFNA21, NFKBIA, STAT1, IL2RB, CD28, HSPA8, BCL2 | More | | Paclitaxel | hsa05166 | Human T-cell leukemia virus 1 infection | 1.77E-02 | 8 | P27824, P30279, P21796, P84022, Q13485, P07766, Q92830, P06746 | CANX, CCND2, VDAC1, SMAD3, SMAD4, CD3E, KAT2A, POLB | More | | Paclitaxel | hsa05168 | Herpes simplex virus 1 infection | 5.65E-04 | 14 | P25963, P01568, P42224, Q07955, Q01130, Q13243, Q13489, P51617, Q13398, Q9NR11, P17097, P17038, Q03923, P10415 | NFKBIA, IFNA21, STAT1, SFRS1, SFRS2, SFRS5, BIRC3, IRAK1, ZNF211, ZNF302, ZNF7, ZNF43, ZNF85, BCL2 | More | | Paclitaxel | hsa05170 | Human immunodeficiency virus 1 infection | 1.21E-06 | 15 | P62873, P0DP23, P17252, Q13546, O00463, Q14643, P01568, P51617, P25963, O60603, Q13315, P23528, P10415, Q93034, Q9Y6Q5 | GNB1, CALM1, PRKCA, RIPK1, TRAF5, ITPR1, IFNA21, IRAK1, NFKBIA, TLR2, ATM, CFL1, BCL2, CUL5, AP1M2 | More | | Paclitaxel | hsa05200 | Pathways in cancer | 2.19E-05 | 27 | P04628, Q13751, P08238, P42224, P25963, P19174, Q9UJU2, P17252, P43246, P84022, Q13485, P20585, P14923, P30279, P10415, Q13489, Q12778, P25116, P62873, P63218, P50151, Q14344, O75293, P0DP23, P01568, P14784, P01042 | WNT1, LAMB3, HSP90AB1, STAT1, NFKBIA, PLCG1, LEF1, PRKCA, MSH2, SMAD3, SMAD4, MSH3, JUP, CCND2, BCL2, BIRC3, FOXO1, F2R, GNB1, GNG5, GNG10, GNA13, GADD45B, CALM1, IFNA21, IL2RB, KNG1 | More | | Paclitaxel | hsa05202 | Transcriptional misregulation in cancer | 3.51E-02 | 11 | Q12778, Q15532, P14780, P14923, Q16548, Q13489, Q13077, P35226, P05164, P08246, Q9C0K0 | FOXO1, SS18, MMP9, JUP, BCL2A1, BIRC3, TRAF1, BMI1, MPO, ELA2, BCL11B | More | | Paclitaxel | hsa05203 | Viral carcinogenesis | 1.90E-02 | 6 | P06746, Q92830, P07948, P30279, P29083, Q93079 | POLB, KAT2A, LYN, CCND2, GTF2E1, H2BC9 | More | | Paclitaxel | hsa05205 | Proteoglycans in cancer | 1.09E-02 | 10 | Q13009, Q12955, Q14643, O75369, P14780, P17252, O60603, P04628, Q13635, P08962 | TIAM1, ANK3, ITPR1, FLNB, MMP9, PRKCA, TLR2, WNT1, PTCH1, CD63 | More | | Paclitaxel | hsa05210 | Colorectal cancer | 1.78E-02 | 3 | P84022, Q13485, P10415 | SMAD3, SMAD4, BCL2 | More | | Paclitaxel | hsa05212 | Pancreatic cancer | 3.52E-02 | 2 | P84022, Q13485 | SMAD3, SMAD4 | More | | Paclitaxel | hsa05214 | Glioma | 2.90E-02 | 3 | P0DP23, Q16566, P17252 | CALM1, CAMK4, PRKCA | More | | Paclitaxel | hsa05215 | Prostate cancer | 6.15E-03 | 5 | P10415, Q9UJU2, Q12778, Q9NRA1, P08238 | BCL2, LEF1, FOXO1, PDGFC, HSP90AB1 | More | | Paclitaxel | hsa05216 | Thyroid cancer | 3.80E-02 | 2 | P01106, O75293 | MYC, GADD45B | More | | Paclitaxel | hsa05220 | Chronic myeloid leukemia | 1.25E-02 | 3 | Q13485, P25963, P84022 | SMAD4, NFKBIA, SMAD3 | More | | Paclitaxel | hsa05222 | Small cell lung cancer | 1.50E-02 | 3 | Q13489, P10415, P25963 | BIRC3, BCL2, NFKBIA | More | | Paclitaxel | hsa05223 | Non-small cell lung cancer | 1.39E-02 | 3 | P10826, Q9HC35, O75293 | RARB, EML4, GADD45B | More | | Paclitaxel | hsa05226 | Gastric cancer | 2.78E-02 | 3 | P84022, Q13485, P10415 | SMAD3, SMAD4, BCL2 | More | | Paclitaxel | hsa05231 | Choline metabolism in cancer | 5.44E-03 | 4 | Q9NRA1, P23743, O14494, P17252 | PDGFC, DGKA, PLPP1, PRKCA | More | | Paclitaxel | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 1.05E-03 | 9 | O95267, P07766, P20963, P09693, P06239, Q04759, Q16539, Q9HC35, P01730 | RASGRP1, CD3E, CD247, CD3G, LCK, PRKCQ, MAPK14, EML4, CD4 | More | | Paclitaxel | hsa05320 | Autoimmune thyroid disease | 8.64E-03 | 4 | P13765, P29965, P01568, P10747 | HLA-DOB, CD40LG, IFNA21, CD28 | More | | Paclitaxel | hsa05340 | Primary immunodeficiency | 1.28E-03 | 4 | P01730, P11912, P07766, P06239 | CD4, CD79A, CD3E, LCK | More | | |